Some anti-TNF-induced pulmonary complications have been identified: infections (TB, bacterial and fungal infections), exacerbations of underlying lung disease, interstitial lung disease (ILD), granulomatous lung disease, systemic lupus erythematosus (SLE)-like reactions and vasculitis [129]. This evidence concerns the gene TNF and vasculitis.